|[December 17, 2012]
NanoLuc™ Luciferase Technology Named to The Scientist Top 10 Innovations for 2012
MADISON, Wis. --(Business Wire)--
Promega Corporation is pleased to announce that The Scientist has
named NanoLuc™ Luciferase Technology to its 2012 Top 10 Innovations.
NanoLuc is a novel luciferase that is smaller, brighter, and more
versatile than any current bioluminescent enzyme.
Promega NanoLuc Luciferase Technology named to The Scientist Top 10 Innovations for 2012 (Photo: Business Wire)
NanoLuc was first commercialized in May 2012 with 12 plasmid constructs
and the Nano-Glo™ Reagent for reporter applications. NanoLuc is an
enabling platform technology upon which Promega is developing additional
assay solutions for difficult biology. The technology has alread
demonstrated its value to viral delivery and protein fusion
applications. The versatility of NanoLuc is being further pursued by the
Advanced Technologies Group and Research & Development teams at Promega.
In addition to in-house development, Promega is collaborating with
complementary next-gen assay technologies to better serve basic and
pharmaceutical research. Key collaborations using NanoLuc include
coupling with 3D cell culture models (InSphero) and combining with
genetically-defined reporter cell lines generated using the proprietary
GENESIS™ gene editing technology (Horizon Discovery Ltd).
To learn more about this enabling technology, request a sample or view a
webinar, please see www.promega.com/nanoluc.
Promega Corporation is a leader in providing innovative solutions and
technical support to the life sciences industry. The company's 2,500
products enable scientists worldwide to advance their knowledge in
genomics, proteomics, cellular analysis, molecular diagnostics and human
identification. Founded in 1978, the company is headquartered in
Madison, WI, USA with branches in 15 countries and over 50 global
distributors. For more information about Promega, visit www.promega.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121217005291/en/
[ Back To Homepage ]